HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immuno-dominant optimal epitopes slow the progression of AIDS in China

Current HIV Research

Volumn 6, Issue 4, 2008, Pages 335-350

  Zhai, Song ^a   Zhuang, Yan ^a   Song, Yang ^a   Li, Shu ^b   Huang, Dedong ^a   Kang, Wenzhen ^a   Li, Xinhong ^a   Liao, Qi ^b   Liu, Yanhou ^b   Zhao, Zhongfang ^b   Lu, Yichen ^b   Sun, Yongtao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

CTL response; HIV 1; HLA allele

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A11 ANTIGEN; HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B35 ANTIGEN; HLA B44 ANTIGEN; HLA B51 ANTIGEN; HLA B7 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALLELE; ANTIGEN RECOGNITION; CELL ISOLATION; CHINESE; CLADISTICS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENTROPY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION GENETICS; REVIEW; SEQUENCE ANALYSIS; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ALLELES; AMINO ACID SEQUENCE; CHINA; DISEASE PROGRESSION; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE PRODUCTS, NEF; HISTOCOMPATIBILITY TESTING; HIV ENVELOPE PROTEIN GP41; HIV-1; HLA ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 52449112959     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016208785132473     Document Type: Review

References (37)

1. Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 2004; 4: 630-40.
2. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13: 46-53.
3. Draenert R, Verrill CL, Tang Y, et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol 2004; 78: 630-41.
4. Zuniga R, Lucchetti A, Galvan P, et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006; 80: 3122-5.
5. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432: 769-75.
6. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107: 4781-9.
7. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193: 169-80.
8. Oxenius A, Price DA, Easterbrook PJ, et al. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci USA 2000; 97: 3382-87.
9. Cao J, McNevin J, Holte S, Fink L, Corey L and McElrath MJ. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J Virol 2003; 77: 6867-78.
10. Yu XG, Addo MM, Rosenberg ES, et al. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol 2002; 76: 8690-701.
11. Goulder PJ, Altfeld MA, Rosenberg ES, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001; 193: 181-94.
12. Altfeld M, Addo MM, Rosenberg ES, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003; 17: 2581-91.
13. Allen TM, Altfeld M, Yu XG, et al. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 2004; 78: 7069-78.
14. Carrington M and O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54: 535-51.
15. Frahm N, Linde CH, Brander C. Identification of HIV-Derived, HLA Class I restricted CTL epitopes: insights into TCR repertoire, CTL escape and viral fitness. In: Korber BTM, Brander C, Haynes BF, et al. Eds. HIV Molecular Immunology 2006; 3-26.
16. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77: 2081-92.
17. Yusim K, Kesmir C, Gaschen B, et al. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002; 76: 8757-68.
18. Zhao S, Zhai S, Zhuang Y, et al. Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China. Curr HIV Res 2007; 5: 251-59.
19. Altfeld M, Kalife ET, Qi Y, et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 2006; 3:e403.
20. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296: 1439-43.
21. Friedrich TC, Dodds EJ, Yant LJ, et al. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 2004; 10: 275-81.
22. Nowak MA, May RM, Phillips RE, et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995; 375: 606-11.
23. Klein MR, van der Burg SH, Hovenkamp E, et al. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. J Gen Virol 1998; 79(Pt 9): 2191-201.
24. Gillespie GM, Kaul R, Dong T, et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 2002; 16: 961-72.
25. Frater AJ, Brown H, Oxenius A, et al. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol 2007; 81: 6742-51.
26. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001; 344: 1668-75.
27. Li S, Jiao H, Yu X, et al. Human leukocyte antigen class I and class II allele frequencies and HIV-1 infection associations in a Chinese cohort. J Acquir Immune Defic Syndr 2007; 44:121-31.
28. Trachtenberg E, Vinson M, Hayes E, et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 2007; 70: 455-63.
29. Sriwanthana B, Hodge T, Mastro TD, et al. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses 2001; 17: 719-34.
30. Trachtenberg E, Korber B, Sollars C, et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003;9:928-935.
31. Scherer A, Frater J, Oxenius A, et al. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci USA 2004; 101: 12266-70.
32. Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 2006; 203: 1357-69.
33. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283:1748-52.
34. Brander C, Hartman KE, Trocha AK, et al. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201- restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest 1998; 101: 2559-66.
35. Iversen AK, Stewart-Jones G, Learn GH, et al. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol 2006; 7: 179-89.
36. Wodarz D, Jansen VA. The role of T cell help for anti-viral CTL responses. J Theor Biol 2001; 211: 419-32.
37. Zhuang Y, Sun Y, Zhai S, et al. Relative dominance of Env-gp41-specific cytotoxic T lymphocytes responses in HIV-1 advanced infection. Curr HIV Res 2008; 6: 239-45.